<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-04-21T08:58:12Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/613" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/613</identifier>
				<datestamp>2012-12-31T23:10:35Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Synthesis, characterization and molecular docking studies of novel  S-substituted phenacyl-1,3,4-thiadiazole-thiol derivatives  as antimicrobial agents</dc:title>
	<dc:creator>Kerur, Shashidhar</dc:creator>
	<dc:creator>Alagawadi, Kallanagouda</dc:creator>
	<dc:creator>Zhu, Hailiang</dc:creator>
	<dc:creator>Manvi, Fakkirappa</dc:creator>
	<dc:subject xml:lang="en-US">1</dc:subject>
	<dc:subject xml:lang="en-US">3</dc:subject>
	<dc:subject xml:lang="en-US">4-Thiadiazole</dc:subject>
	<dc:subject xml:lang="en-US">Phenacyl bromide</dc:subject>
	<dc:subject xml:lang="en-US">Molecular docking</dc:subject>
	<dc:subject xml:lang="en-US">Antimicrobial activity</dc:subject>
	<dc:subject xml:lang="en-US">Antitubercular activity</dc:subject>
	<dc:subject xml:lang="en-US">Mycobacterium tuberculosis</dc:subject>
	<dc:description xml:lang="en-US">In the present study, synthesis and antimicrobial activity of 2,5-disubstituted 1,3,4-thiadiazole derivatives 5a-f are described. The structures of the newly synthesized compounds were confirmed by FT-IR, 1H NMR, 13C NMR, mass and elemental analysis. All compounds were screened for antitubercular and antimicrobial activity. Molecular modeling studies were performed to dock compounds into the ecKAS III binding site, which suggested probable inhibition mechanism. The results revealed that most of the compounds showed high to moderate biological activity against tested microorganisms.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2012-09-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/613</dc:identifier>
	<dc:identifier>10.5155/eurjchem.3.3.293-297.613</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 3 No. 3 (2012): September 2012; 293-297</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/613/PDF</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
